The Zabludowicz Center for Autoimmune Diseases and Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel.
Ann Rheum Dis. 2011 Jan;70(1):145-50. doi: 10.1136/ard.2010.134817. Epub 2010 Oct 27.
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by thrombosis, obstetric complications and the presence of anti-phospholipid antibodies such as anti-β2GPI-Abs. These antibodies may set off the coagulation cascade via several mechanisms, including the induction of tissue factor (TF) expression. Vitamin D has recently emerged as an immunomodulator that might exert an anti-thrombotic effect. Therefore, we studied serum vitamin D levels in a cohort of APS patients, as well as the effect of vitamin D in an in vitro model of APS-mediated thrombosis.
Serum vitamin D levels were measured in 179 European APS patients and 141 healthy controls using the LIAISON chemiluminescent immunoassay, and the levels were evaluated in conjunction with a wide spectrum of clinical manifestations. In an vitro model, anti-β2GPI antibodies were purified from four patients with APS to evaluate the expression of TF in activated starved human umbilical vein endothelial cells. The effect of vitamin D (1,25-dihydroxyvitamin D, 10 nm) on anti-β2GPI-Abs mediated TF expression was analysed by immunoblot.
Vitamin D deficiency (serum level ≤15 ng/ml) was documented in 49.5% of our APS patients versus 30% of controls (p<0.001) and was significantly correlated with thrombosis (58% vs 42%; p<0.05), neurological and ophthalmic manifestations, pulmonary hypertension, livedo reticularis and skin ulcerations. In vitro vitamin D inhibited the expression of TF induced by anti-β2GPI-antibodies.
Vitamin D deficiency is common among APS patients and is associated with clinically defined thrombotic events. Vitamin D inhibits anti-β2GPI-mediated TF expression in vitro. Thus, vitamin D deficiency might be associated with decreased inhibition of TF expression and increased coagulation in APS. Evaluation of vitamin D status and vitamin D supplementation in APS patients should be considered.
抗磷脂综合征(APS)是一种以血栓形成、产科并发症和存在抗磷脂抗体(如抗β2GPI-Abs)为特征的系统性自身免疫性疾病。这些抗体可能通过多种机制引发凝血级联反应,包括诱导组织因子(TF)表达。维生素 D 最近作为一种免疫调节剂出现,可能具有抗血栓作用。因此,我们研究了一组 APS 患者的血清维生素 D 水平,以及维生素 D 在 APS 介导的血栓形成体外模型中的作用。
采用 LIAISON 化学发光免疫分析法检测 179 例欧洲 APS 患者和 141 例健康对照者的血清维生素 D 水平,并结合广泛的临床表现进行评估。在体外模型中,从 4 例 APS 患者中纯化抗β2GPI 抗体,以评估激活饥饿状态下人脐静脉内皮细胞中 TF 的表达。通过免疫印迹分析维生素 D(1,25-二羟维生素 D,10nm)对抗β2GPI-Abs 介导的 TF 表达的影响。
我们的 APS 患者中 49.5%存在维生素 D 缺乏(血清水平≤15ng/ml),而对照组为 30%(p<0.001),且与血栓形成(58% vs 42%;p<0.05)、神经和眼科表现、肺动脉高压、网状青斑和皮肤溃疡显著相关。体外维生素 D 抑制了抗β2GPI 抗体诱导的 TF 表达。
维生素 D 缺乏在 APS 患者中很常见,与临床上定义的血栓形成事件相关。维生素 D 抑制体外抗β2GPI 介导的 TF 表达。因此,维生素 D 缺乏可能与 TF 表达抑制减少和 APS 中凝血增加有关。应考虑评估 APS 患者的维生素 D 状态和补充维生素 D。